ESCRS - PO981 - The Clinical Observation Of Olopatadine Hydrochloride And Topical Fk506 In Treating Severe Vernal Keratoconjunctivitis Of Children.

The Clinical Observation Of Olopatadine Hydrochloride And Topical Fk506 In Treating Severe Vernal Keratoconjunctivitis Of Children.

Published 2025 - 43rd Congress of the ESCRS

Reference: PO981 | Type: Poster | DOI: 10.82333/cx7b-kw22

Authors: Faisal Alharbi* 1

1AIR BASE HOSPITAL,DAMMAM,Saudi Arabia

Purpose

Purpose: To observe the clinical effect of eye drops of 0.1% olopatadine hydrochloride ( patanol) and 0.05% FK506 (tacrolimus) for treating severe vernal keratoconjunctivitis.

Setting

Setting: Department of Ophthalmology, Air Base Hospital, Saudi Arabia.

Methods

Methods: We observed the symptoms and signs of 31 cases of severe vernal keratoconjunctivitis before and after the treatment of 0.1% olopatadine hydrochloride and 0.05% FK506. We examined the blood routine and the biochemical functions for all patients regularly. 

Results

 Results: Following by 24months, all patients were much better than before in differently degree in 1 week. The papillae were decreased and almost disappeared gradually in 1 month.
The corneal lesions were cured rapidly in less than 2 weeks. 19 cases (61.3% ) recurred in 2weeks to 8 months after stoping the eye drops.

Conclusions

Conclusions:0.1% olopatadine hydrochloride and 0.05% of sever  vernal  keratoconjunctivitis, the patients are comfortable 
and content with the treatment, side effects are very few.